Craig Wong-Pan

Stock Analyst at RBC Capital

(0.78)
# 4,174
Out of 5,134 analysts
347
Total ratings
47.1%
Success rate
-2.3%
Average return

Stocks Rated by Craig Wong-Pan

ResMed
Oct 30, 2026
Reiterated: Buy
Price Target: $262 → $288
Current: $239.53
Upside: +20.24%
Integral Diagnostics Limited
Oct 29, 2026
Reiterated: Buy
Price Target: $3.20 → $2.80
Current: $1.66
Upside: +68.67%
Australian Clinical Labs Limited
Oct 28, 2026
Reiterated: Hold
Price Target: $2.40 → $2.75
Current: $3.37
Upside: -18.40%
Healius Limited
Oct 22, 2026
Reiterated: Hold
Price Target: $0.42 → $0.46
Current: $0.59
Upside: -22.03%
Telix Pharmaceuticals Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $21.00
Current: $13.48
Upside: +55.79%
CSL Limited
Oct 6, 2026
Reiterated: Buy
Price Target: $213.00 → $215.00
Current: $202.08
Upside: +6.39%
Ansell Limited
Sep 15, 2026
Downgraded: Hold
Price Target: $36.00 → $38.00
Current: $46.66
Upside: -18.55%
Cochlear Limited
Sep 15, 2026
Reiterated: Hold
Price Target: $117.00
Current: $150.54
Upside: -22.28%
Nanosonics Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $3.00 → $3.75
Current: $2.83
Upside: +32.51%
Regis Healthcare Limited
Sep 15, 2026
Reiterated: Hold
Price Target: $5.00
Current: $5.15
Upside: -2.91%
Upgraded: Buy
Price Target: $52.00 → $68.00
Current: $54.59
Upside: +24.56%
Reiterated: Hold
Price Target: $21.00
Current: $19.88
Upside: +5.66%
Upgraded: Buy
Price Target: $39.00 → $52.00
Current: $48.46
Upside: +7.30%
Downgraded: Hold
Price Target: $81
Current: $132.41
Upside: -39.17%
Reiterated: Hold
Price Target: $0.75 → $0.72
Current: $0.75
Upside: -3.68%
Reiterated: Hold
Price Target: $0.12 → $0.13
Current: $1.21
Upside: -89.26%
Reiterated: Sell
Price Target: $16.04
Current: $26.33
Upside: n/a
Reiterated: Buy
Price Target: $31.60
Current: $14.24
Upside: n/a
Downgraded: Sell
Price Target: $6.57
Current: $21.20
Upside: n/a